Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation

Published:2008-02 Issue:2 Volume:31 Page:199-206
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Feuchtinger Tobias,Richard Celine,Joachim Stefanie,Scheible Michael H.,Schumm Michael,Hamprecht Klaus,Martin David,Jahn Gerhard,Handgretinger Rupert,Lang Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference43 articles.

1. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations;Lewin;Blood,2002

2. Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism;Bahceci;Br J Haematol,2003

3. Immunological aspects of haploidentical stem cell transplantation in children;Handgretinger;Ann N Y Acad Sci,2001

4. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia;Lang;Blood,2003

5. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen;Mohty;Leukemia,2003

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children;Transplantation and Cellular Therapy;2023-06

2. The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease;Molecular Therapy;2022-06

3. Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections;Molecular Therapy;2022-01

4. Adenoviruses;Viral Infections of Humans;2022

5. Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer;Nature Communications;2021-12